CRS/HIPEC Improves Survival in Low-Grade Appendiceal Carcinoma
CRS/HIPEC significantly enhances survival for select low-grade appendiceal carcinoma patients with peritoneal and parenchymal metastases.
Newsletter
Every new paper in this field, in your inbox.
CRS/HIPEC significantly enhances survival for select low-grade appendiceal carcinoma patients with peritoneal and parenchymal metastases.
Total neoadjuvant therapy (TNT) significantly improves response and survival in high-risk rectal cancer patients.
A modified SMA approach improves outcomes for laparoscopic right colectomy in colon cancer patients.
Transanal endoluminal surgery (TES) shows significant advantages over endoscopic submucosal dissection (ESD) for T1 rectal cancer.
Surgeons can now better predict the risk of peristomal irritant dermatitis after colostomy surgery, enhancing patient care.
This study aims to clarify the safety concerns surrounding laparoscopic right-sided colectomy for colon cancer, which has unexpectedly high complication rates.
Robotic colorectal surgery leads to significantly shorter hospital stays compared to laparoscopic and open techniques.
Surgeons can now better identify patients at risk for stoma prolapse after colorectal cancer surgery.
Prophylactic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) offers significantly improved survival for patients with perforated appendiceal adenocarcinoma.
A new hybrid parastomal endoscopic repair (HyPER) demonstrates effectiveness for complex hernia cases.